Arterial elasticity in cardiovascular disease: Focus on hypertension, metabolic syndrome and diabetes

Advances in Cardiology

Volumn 45, Issue , 2008, Pages 65-81

  Cernes, R ^a,b   Zimlichman, R ^a,b   Shargorodsky, M ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; FIBRONECTIN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN;

ARTERY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; ELASTICITY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULSE RATE; REVIEW;

ARTERIES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; ELASTICITY; ELASTIN; FIBRONECTINS; HUMANS; HYPERTENSION; MATRIX METALLOPROTEINASES; METABOLIC SYNDROME X; OBESITY; PROTEOGLYCANS; PULSE;

EID: 43749083759     PISSN: 00652326     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000115188     Document Type: Review

References (78)

1. Hayden MR, Sowers JR, Tyagi SR: The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 2005;4:9.
2. Siperstein MD: Diabetic microangiopathy and the control of blood glucose. N Engl J Med 1983;309:1577-1599.
3. Klein RF, Feingold KR, Morgan C, Stern WH, Siperstein MD: Relationship of muscle capillary basement membrane thickness and diabetic retinopathy. Diabetes Care 1987;10:195-199.
4. London GM, Marchais SJ, Guerin AP, et al: Arterial structure and function in end-stage renal failure. Nephrol Dial Transplant 2002;17:1713-1724.
5. O'Rouke MF, Kelly RP: Wave reflection in the systemic circulation and its implication in the ventricular function. J Hypertens 1993;11:327-337.
6. Izzo JL Jr: Hypertension in elderly: a pathophysiologic approach to therapy. J Am Geriatr Soc 1982;30:352-359.
7. Tozawa M, et al: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002;61:717-726.
8. Chadwick RS, et al: Pulse-wave model of brachial arterial pressure modulation in aging and hypertension. Am J Physiol 1986;251:H1-H11.
9. Seyrek N, et al: Which parameter is more influential on the development of arteriosclerosis in hemodialysis patients? Ren Fail 2003;25:1011-1018.
10. Mourad JJ, Pannier B, Blacher J, et al: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001;59:1834-1841.
11. Covic A, et al: Arterial stiffness in renal patients: an update. Am J Kidney Dis 2005;45:965-977.
12. Reneman RS, Meinders JM, Hoeks APG: Non-invasive ultrasound in arterial wall dynamics in humans: what have we learned and what remains to be solved. Eur Heart J 2005;26:960-966.
13. Bussy C, Boutouyrie P, Lacolley P, et al: Intrinsic stiffness of the carotid arterial wall in essential hypertensives. Hypertension 2000;35:1049-1054.
14. Blacher J, Protogerou AD, Safar ME: Large artery stiffness and antihypertensive agents. Curr Pharmaceut Design 2005;11:3317-3326.
15. Izzo JL Jr: Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol 2004;19:341-352.
16. Safar ME, Blacher J, et al: Stiffness of carotid artery wall material and blood pressure in humans. Stroke 2000;3:782-790.
17. Kass DA: Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005;46:185.
18. Schiffrin EL: Remodeling of resistance arteries in essential hypertension and effects of anthypertensive treatment. AJH 2004;17:1192-1200.
19. Vasan RS, Larson MG, Levy D: Determinants of echocardiographic aortic root size: the Framingham Heart Study. Circulation 1995;91:734-740.
20. Schiffrin EL: Reactivity of small blood vessels in hypertension: relation with structural changes. Hypertension 1992;19(suppl II):II-1-II-9.
21. Schiffrin EL, Park JB, Intengan HD, et al: Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin antagonist losartan. Circulation 2000;101:1653-1659.
22. Serne EH, Gans ROB, et al: Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2000;38:238-242.
23. Et-Taouil K, Safar M, Plante GE: Mechanisms and consequences of large artery rigidity. Can J Physiol Pharmacol 2003;81:205-211.
24. Aronson D: Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003;21:3-12.
25. Lehmann ED, Riley WA, et al: Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 1997;350:SI14-SI19.
26. Riggs TW, Transue D: Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990;65:899-902.
27. Poirier P, Bogaty P, et al: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance in maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10.
28. Brownlee M, Cerami A, Vlassara H: Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-1321.
29. Ferrier KE, Muhlmann MH, et al: Intensive cholesterol reduction lowers blood pressure and large arterial stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002;39:1020-1025.
30. Liang Yl, Shiel LM, et al: Effects of blood pressure, smoking and their interaction on carotid artery structure and function. Hypertension 2001;37:6-11.
31. Jennings GLR, Kingwell BA: Measuring arterial function in diabetes. J Hypertens 2004;22:1863-1865.
32. Lacy PS, O'Brien DG, et al: Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004;22:1937-1944.
33. Lim HS, Lip GYH: Arterial stiffness in diabetes and hypertension. J Hum Hypertens 2004;18:467-468.
34. Shargorodsky M, Fleed A, Boaz M, Gavish D, Zimlichman R: The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity. Int J Obes 2006;30:1632-1638.
35. Montagni M, Quon MJ: Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000;2:285-292.
36. Rizzoni D, Porteri E, et al: Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001;103:1238-1244.
37. Sorensen TIA, Rissansen A, et al: Intention to lose weight, weight changes, and 18-year mortality in overweight individuals without co-morbidities. Plos Med 2005;2:e171.
38. Grey E, Bratelli C, et al: Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 2003;16:265-269.
39. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Curr Opin Cardiol 2006;21:1-6.
40. Mule G, Nardi E, Cottone S, et al: Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. AJH 2007;20:197-203.
41. Mule G, Nardi E, Cottone S, et al: Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005;257:503-513.
42. Van Popele NM, Westendorp ICD, Bots ML, et al: Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia 2000;43:665-672.
43. Vlachopoulos C, Aznaouridis K, Stefanidis C: Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart 2006;92:1544-1550.
44. Keith DS, Nichols GA, Gullion CM, et al: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
45. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
46. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004;351:1296-1305.
47. Covic A, Mardare N, Gusbech-Tatomir P, et al: Arterial wave reflections and mortality in hemodialysis patients - only relevant in elderly, cardiovascularly compromised? Nephrol Dial Transplant 2006;21:2859-2866.
48. Goldsmith DJ, Ritz E, Covic A: Vascular calcification - a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004;66:1315-1333.
49. Goodman WG, Goldin J, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
50. Chertow GM, et al: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
51. He ZX, Hedrick TD, et al: Severity of artery calcification by EBCT predicts silent myocardial ischemia. Circulation 2000;101:244-251.
52. Winkelmayer WC, Glynn RJ, Mittleman MA, et al: Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002;13:2353-2362.
53. Covic A, Goldsmith DJ, Gusbeceth-Tatomir P, et al: Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003;76:1573-1577.
54. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 2004;43:234-243.
55. Teede HJ, McGrafth BP, DeSilva L, et al: Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003;23:1066-1071.
56. Vlachopoulos C, Aznaouridis K, et al: Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 2005;18:785-791.
57. Nichols WW, Estrada JC, Braith RW, et al: Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol 2006;48:1208-1214.
58. Kahonen M, Ylitalo R, Koobi T, et al: Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers. Int J Clin Pharmacol Ther 1998;36:483-489.
59. Leibovitz E, Beniashvili M, Zimlichman R, Freiman A, Shargorodsky M, Gavish D: Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients. Am J Hypertens 2003;16:715-718.
60. Kelly RP, Millasseau SC, Ritter JM, et al: Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001;37:1429-1433.
61. Safar ME, Avolio A: Aldosterone antagonism and arterial stiffness. Hypertension 2004;43:e3.
62. Shargorodsky M, Leibovitz E, Lubimov L, Gavish D, Zimlichman R: Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension. Am J Hypertens 2002;15:1087-1091.
63. Mahmud A, Feely J: Effect of angiotensin II receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002;15:1092-1095.
64. Mahmud A, Feely J: Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002;15:321-325.
65. Benetos A, Cambien F, Gautier S: Influence of the angiotensin type 1receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996;28:1081-1084.
66. Mitchell GF, Izzo JL Jr, et al: Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002;105:2955-2961.
67. Safar ME: Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation 2001;103:1188-1190.
68. Kass DA, Shapiro EP, Kawaguchi M, et al: Improved arterial compliance by a novel advanced glycation end product crosslink breaker. Circulation 2001;104:1464-1470.
69. Kass DA: Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005;46:185.
70. Shargorodsky M, Wainstein J, Gavish D, Leibovitz E, Matas Z, Zimlichman R: Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. Am J Hypertens 2003;16:617-622.
71. Ichihara A, Hayashi M, Ryuzaki M, et al: Fluvastatin prevents development of arterial stiffness in hemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002;17:1513-1517.
72. Ohta K, Nakajima T, et al: Elafin-overexpressing mice have improved cardiac function after myocardial infarction. Am J Physiol 2004;287:H286-H292.
73. Vlachopoulos C, Hirata K, O'Rouke MF: Effect of sildenafil on arterial stiffness and wave reflection. Vasc Med 2003;8:243-248.
74. Aakhus S, Dahl K, Widerøe TE: Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999;14:648-654.
75. Ferro CJ, Savage T, Pinder SJ, et al: Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002;62:166-171.
76. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al: Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003;76:1573-1577.
77. Zoungas S, Kerr PG, Chadban S, et al: Arterial function after successful renal transplantation. Kidney Int 2004;65:1882-1889.
78. Laurent S, Boutuyrie P, Lacolley P: Structural and genetic bases of arterial stiffness. Hypertension 2005;45:1050.